Series C brings in $28.5mm for Baxano
Spinal device company Baxano Inc. has raised $28.5mm out of a potential $30mm in its Series C equity financing led by first-time backer CMEA Capital, which was joined by other new investors Kaiser Permanente Ventures and Affinity Capital Management, returning shareholders Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners, and six undisclosed investors. The company will apply the money towards the US launch of its iO-Flex system for lumbar stenosis and for post-clearance clinical trials.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com